NCT00810862

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

A 3-Week, Single-Blind, Placebo-Controlled, Within-Patient, Randomized Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Children's Hospital of Michigan · Academic / Other
• Sex: All
• Age: 2 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

Primecrolimus cream 1% is effective in the treatment of atopic dermatitis in African American children.

Conditions

• Atopic Dermatitis

Interventions

Type	Name	Description
DRUG	pimecrolimus active cream	Pimecrolimus 1% cream apply to affected study area twice daily for 21 days
OTHER	placebo base cream	apply to affected study area twice daily for 21 days

Timeline

• Start date: 2006-11-01
• Primary completion: 2008-06-01
• Completion: 2008-06-01
• First posted: 2008-12-18
• Last updated: 2008-12-18